🇺🇸 FDA
Patent

US 8734786

Use of ECDI-fixed cell tolerance as a method for preventing allograft rejection

granted A61KA61K2239/31A61K2239/38

Quick answer

US patent 8734786 (Use of ECDI-fixed cell tolerance as a method for preventing allograft rejection) held by Northwestern University expires Mon May 22 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Northwestern University
Grant date
Tue May 27 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 22 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K2239/31, A61K2239/38, A61K35/18, A61K35/22